M. Demirel, Ibrahim Donmez, E. Uçaroğlu, A. Yüksel
{"title":"急性冠状动脉综合征及其诊断方法","authors":"M. Demirel, Ibrahim Donmez, E. Uçaroğlu, A. Yüksel","doi":"10.15761/mri.1000167","DOIUrl":null,"url":null,"abstract":"Despite decreased incidence and mortality rates in recent years, coronary heart diseases remain one of the leading causes of death. According to TEKHARF study by the Turkish Cardiology Society, 2 million people have coronary artery disease in Turkey. According to TEKHARF data, cardiovascular diseases are responsible for 45% of all deaths in our country [3]. It is estimated that the number of patients with heart disease will reach 3.4 million if this negative situation, similar to the rates in developed countries, continues [2].","PeriodicalId":93126,"journal":{"name":"Medical research and innovations","volume":"6 1","pages":""},"PeriodicalIF":0.0000,"publicationDate":"2019-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"2","resultStr":"{\"title\":\"Acute coronary syndromes and diagnostic methods\",\"authors\":\"M. Demirel, Ibrahim Donmez, E. Uçaroğlu, A. Yüksel\",\"doi\":\"10.15761/mri.1000167\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Despite decreased incidence and mortality rates in recent years, coronary heart diseases remain one of the leading causes of death. According to TEKHARF study by the Turkish Cardiology Society, 2 million people have coronary artery disease in Turkey. According to TEKHARF data, cardiovascular diseases are responsible for 45% of all deaths in our country [3]. It is estimated that the number of patients with heart disease will reach 3.4 million if this negative situation, similar to the rates in developed countries, continues [2].\",\"PeriodicalId\":93126,\"journal\":{\"name\":\"Medical research and innovations\",\"volume\":\"6 1\",\"pages\":\"\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2019-01-01\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"2\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical research and innovations\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.15761/mri.1000167\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical research and innovations","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.15761/mri.1000167","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Despite decreased incidence and mortality rates in recent years, coronary heart diseases remain one of the leading causes of death. According to TEKHARF study by the Turkish Cardiology Society, 2 million people have coronary artery disease in Turkey. According to TEKHARF data, cardiovascular diseases are responsible for 45% of all deaths in our country [3]. It is estimated that the number of patients with heart disease will reach 3.4 million if this negative situation, similar to the rates in developed countries, continues [2].
求助内容：
应助结果提醒方式：
京公网安备 11010802042870号
